Key Points GAAP revenue surged to $4.0 million in Q2 2025, beating analyst expectations by 381.9%. GAAP net loss per share improved to $(0.50) in Q2 2025, slightly better than the estimated $(0.52).

LMO2 is an intrinsically disordered transcription factor activated in T cell leukaemia that is difficult to target. It forms part of a multiprotein complex that has bipartite DNA binding through ...

The Fund returned approximately +14% during the second quarter, bringing our YTD returns to under +1%. Read more here.

Trailhead Biosystems expands iPSC-derived portfolio with TrailBio Hematopoietic Progenitor Cells: Beachwood, Ohio Wednesday, August 6, 2025, 16:00 Hrs [IST] Trailhead Biosystems, ...

This study reports important negative results by showing that genetic removal of the RNA-binding protein PTBP1 in astrocytes is not sufficient to induce their conversion into neurons, challenging ...

ZUG, Switzerland and BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

Senior author and evolutionary biology professor Eamonn Mallon explained: "It’s like the wasps who took a break early in life ...

Researchers at Kyoto University have discovered that an immune molecule found only in primates, called IGFL2, plays a key role in regulating ...

Novel allogeneic stem cells and differentiated iPSCs are providing more physiologically relevant disease models.

These soluble protein agonists can replicate Notch activation in suspension culture, opening the door to scalable T-cell therapies.

Tumors of the pancreas seldom cause symptoms in their early stages. This means that in many cases, they are not diagnosed until late, when the chances of successful treatment are poor. A new ...

Women and people assigned female at birth can't get prostate cancer, but they can get a similar type, called Skene's gland ...